Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Apocynum venetum extract is a botanical extract derived from the leaves of Apocynum venetum, a perennial plant found in Asia, Europe, and North America. It is known for its wide range of pharmacological activities, including **antidepressant**, **anxiolytic**, **cardioprotective**, **antihypertensive**, **sedative**, **diuretic**, **sleep-promoting**, **anti-aging**, and **anti-inflammatory** effects[1][2][4][5]. The extract contains active flavonoids such as hyperoside, isoquercitrin, rutin, astragaloside, and quercetin. Mechanisms of action include inhibition of neuronal apoptosis (by regulating levels and activity of Bcl-2, Bax, caspase-3, caspase-9, cytochrome c, BDNF, and CREB)[1]; modulation of monoamine neurotransmitters including norepinephrine and dopamine[1]; cardioprotection via AKT/Bcl-2 signaling and reduction of doxorubicin-induced toxicity through modulation of gut microbiota and organic acids[2]; and reduction of blood pressure and cardiovascular risk[4]. It is used as a **dietary supplement** in Japan (notably as Venetron) and as a **phytopharmaceutical or herbal remedy** in China for insomnia, kidney disease, hypertension, heart palpitations, and mood disorders[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on apocynum venetum extract.